Case Study Banner

CASE STUDY

Pharma Company Achieved a Centralized Portfolio View and Maximized Portfolio Value with Clairvoyance

industry-iconCLIENT :Confidential
industry-iconINDUSTRY :Pharmaceutical
industry-iconDURATION :6 months
CLIENT :
Confidential
INDUSTRY :
Pharmaceutical
DURATION :
6 months

Business case

Data-driven decision making is crucial to minimizing business risk and maximizing portfolio value. A global pharmaceutical company was struggling to access timely and accurate operational and financial project metrics such project delivery milestone dates, development cost forecast, revenue forecasts, Probability of Technical and Regulatory Success (PTRS), etc. The decision makers also needed value metrics such as estimated Net Present Value (eNPV) and estimated Internal Rate of Return (eIRR) to estimate the commercial viability of the drugs within the portfolio.

Assessing these projects metrics across project development scenarios and in the context of the whole portfolio is essential for portfolio directors and decision-makers to inform consequential portfolio investment decisions.

Resolving data trust issues caused by data silos, data disparity and data misalignment; and the need to centralize the comparison and visualization of project data against the broader portfolio were the key challenges that prompted improvement in their decision-making capabilities. The client needed a way to access timely and accurate portfolio data all in one place. 

Benefits

  • Decision-makers empowered to interactively monitor and evaluate portfolio performance.
  • Automating data aggregation and report generation saved time and resources.
  • Timely alerts and access to detailed project-level information led to timely risk mitigation.
  • Access to real-time project data fosters a culture of accountability and transparency.
  • Scalable and customizable solution accommodates growing portfolio needs.

Results

Results